Amgen Inc. (BVMF:AMGN34)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of BRL 843.84 billion. The enterprise value is 1.11 trillion.

Market Cap	843.84B
Enterprise Value	1.11T

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	Aug 21, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	537.00M

Valuation Ratios

The trailing PE ratio is 23.40 and the forward PE ratio is 14.17.

PE Ratio	23.40
Forward PE	14.17
PS Ratio	4.44
PB Ratio	20.85
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.43, with an EV/FCF ratio of 19.14.

EV / Earnings	30.67
EV / Sales	5.82
EV / EBITDA	12.43
EV / EBIT	18.92
EV / FCF	19.14

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 7.57.

Current Ratio	1.31
Quick Ratio	0.82
Debt / Equity	7.57
Debt / EBITDA	3.44
Debt / FCF	5.30
Interest Coverage	3.11

Financial Efficiency

Return on equity (ROE) is 99.14% and return on invested capital (ROIC) is 10.15%.

Return on Equity (ROE)	99.14%
Return on Assets (ROA)	7.51%
Return on Invested Capital (ROIC)	10.15%
Return on Capital Employed (ROCE)	15.93%
Revenue Per Employee	6.79M
Profits Per Employee	1.29M
Employee Count	28,000
Asset Turnover	0.39
Inventory Turnover	1.47

Taxes

In the past 12 months, Amgen has paid 4.39 billion in taxes.

Income Tax	4.39B
Effective Tax Rate	10.84%

Stock Price Statistics

The stock price has decreased by -12.92% in the last 52 weeks. The beta is 0.48, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-12.92%
50-Day Moving Average	57.40
200-Day Moving Average	59.10
Relative Strength Index (RSI)	38.80
Average Volume (20 Days)	114

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.63

Income Statement

In the last 12 months, Amgen had revenue of BRL 190.26 billion and earned 36.07 billion in profits. Earnings per share was 66.64.

Revenue	190.26B
Gross Profit	131.96B
Operating Income	58.51B
Pretax Income	40.45B
Net Income	36.07B
EBITDA	87.99B
EBIT	58.51B
Earnings Per Share (EPS)	66.64

Balance Sheet

The company has 43.74 billion in cash and 306.24 billion in debt, giving a net cash position of -262.50 billion.

Cash & Cash Equivalents	43.74B
Total Debt	306.24B
Net Cash	-262.50B
Net Cash Per Share	n/a
Equity (Book Value)	40.47B
Book Value Per Share	75.19
Working Capital	34.10B

Cash Flow

In the last 12 months, operating cash flow was 65.46 billion and capital expenditures -7.67 billion, giving a free cash flow of 57.78 billion.

Operating Cash Flow	65.46B
Capital Expenditures	-7.67B
Free Cash Flow	57.78B
FCF Per Share	n/a

Margins

Gross margin is 69.36%, with operating and profit margins of 30.75% and 18.96%.

Gross Margin	69.36%
Operating Margin	30.75%
Pretax Margin	21.26%
Profit Margin	18.96%
EBITDA Margin	46.25%
EBIT Margin	30.75%
FCF Margin	30.37%

Dividends & Yields

This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 2.33%.

Dividend Per Share	1.30
Dividend Yield	2.33%
Dividend Growth (YoY)	16.05%
Years of Dividend Growth	11
Payout Ratio	1.95%
Buyback Yield	-0.19%
Shareholder Yield	2.15%
Earnings Yield	4.27%
FCF Yield	6.85%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 28.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	28

Scores

Amgen has an Altman Z-Score of 1.68 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.68
Piotroski F-Score	7